1

CURRICULUM VITAE

Prof. SANJEEV MISRA MBBS, MS, MCh (Surg. Oncology), FRCS (England), FRCS (Glasgow), FACS (USA), FICS, FAMS, FNASc

Director & CEO All India Institute of Medical Sciences,

Jodhpur, Rajasthan – 342005

Name Institution University____

I. Primary Qualification

MBBS King George’s Lucknow University

Medical College

Lucknow, India

II. Postgraduate Qualifications

MS King George’s Lucknow University

(General Surgery) Medical College

Lucknow, India

MCh Kidwai Memorial Institute of University of Bangalore

(Surgical Oncology) Oncology, Bangalore,

Karnataka

AWARDS

1. Pfizer Post Graduate Medical Award of Rs. 2000/- with Medallion and Scroll of

Honour in 1989 for distinguished performance at Final year MBBS examination.

2

2. Certificate of Appreciation from Association of Surgeons of India for present-

ing an educative paper as an undergraduate student (for the first time by any undergraduate student) on a "Morphological study of superior mesenteric artery

of Indians" at 44th Annual Conference of the Association at Lucknow on 28th De-

cember, 1984.

3. Dr. R.K. Garg Memorial Best Paper award for post graduate 1991 on "Evaluation

of B Bile composition as an indicator of nature of nature Gall Stones in patients of

cholelithiasis" by the U.P. Chapter of the Association of Surgeons of India at Kan-

pur, Uttar Pradesh for best MS (Gen. Surgery) thesis by a MS postgraduate in the state of Uttar Pradesh.

4. Gulbarga Sharana Basawweswara Award for M.Ch. postgraduates for presen-

tation on "Extended resections for Thyroid Malignancies" by Karnataka State

Chapter Association of Surgeons of India at Mysore, 1994.

5. Best Poster Award at the Ninth International Congress on Anticancer Treat-ment, Feb 2-5 1999, Paris France for presentation on "p 53 tumour Suppresser

Gene and Newer Chemotherapy Protocols in Cancer Gallbladder".

6. Special Invitee to the Annual Conference of British Association of Surgical Oncol-

ogy 26, 27 Nov 2007 at Royal College of Surgeons of England.

7. Special Invitee to the Annual Conference of British Association of Surgical Oncol-

ogy 3 4, Nov 2008 at the Royal College of Surgeons of England

8. Fellow of Royal College of Surgeons of England ad eundem – 2008. The Fel-

lowship ad eundem is awarded to a selected few surgeons in the world in recogni-

tion of their scientific contribution.

9. Awarded International Guest Scholarship of American College of Surgeons, USA for the year 2009.

10. Fellow of Royal College of Surgeons of Glasgow ad eundem – 2013. The Fel-

lowship ad eundem is awarded to a selected few surgeons in the world in recogni-

tion of their scientific contribution.

3

11. Honorary Membership of British Association of Surgical Oncology for contribution

to Oncology.

12. Selected for conferment of DSC (Honoris Causa) by HNB Uttarakhand Medical Education University, Dehradun: To be awarded in their Convocation in 2020.

13. Excellence in Administration Award during 26th Official Conference of IMA Rajasthan and 1st Official conference of ARISDA on 29th-30th June 2019 at Jaipur.

14. Veer Durgadas Rathore Samman, Rajasthan on 27th August 2015.

ORATIONS

1. Dr S N Mathur Oration of UP Chapter of Association of Surgeons of India, 2006.

Topic Our Experience of Carcinoma Penis – A challenging Problem of the Develop-

ing World at Allahabad, 2006

2. Shri Tulsi Sunder Das Sewa Kendra Trust Award of Honour and Lecture, at

12th Annual Conference of Association of Otolaryngologists of India, Haryana State

and 4th Live Surgical workshop, 25 -26 Nov 2006 Topic ‘Management of Neck Nodes

in Oral and Oropharyngeal cancer’

3. Dr Jaipal Singh Memorial Oration of Association of Surgeons of India, 2007 on

“Adult Soft Tissue Sarcoma – A Multidisciplinary Approach”

4. Dr SC Misra Oration of UP Chapter of Association of Surgeons of India, 2010.

Topic ‘Multidisciplinary Management of Adult Soft Tissue Sarcoma – Our Experi-

ence’ at Kanpur, Nov 20, 2010.

5. Dr SP Srivastava Oncology Oration UP Chapter Association of Surgeons of India

2012 – Current Perspectives in Carcinoma Gallbladder.

6. Mrs. Manju Seth Endowment Lecture 2012, Manju Seth Foundation, Indian Insti-

tute of Toxicology Research, Lucknow 31 Dec 2012.

7. Dr SC Purohit Memorial Oration 2013, Western Railway Hospital, Jodhpur, 17 April 2013.

4

8. Col Sangham Lal Memorial Oration of National Academy of Medical Sciences, New Delhi at AIIMS, Rishikesh, Oct 2014.

9. KL Gupta Memorial Oration of Association of Clinical Biochemists of India (ACBI) during 41ST Annual Conference of ACBI, 11-13 Dec 2014, Jodhpur, Raja-

sthan, India. Topic – Cancer Control and Screening of Cancer in India.

10. Smt. Radha Devi Oration of Indian Association of Surgical Oncology, 18th - 21st Sept, 2014, Chennai.

11. Late Shri Girdhari Lal Raturi Oration of Indian Medical Association, Dehradun, Uttarakhand 24th Dec 2016. Topic - Carcinoma Gallbladder.

12. Indira Gandhi Oration on the 9th Annual Day Celebration National Eastern Indira

Gandhi Regional Institute of Health & Medical Sciences (NEIGRIHMS) on 1st March

2019.

OTHER ACADEMIC ASSIGNEMENTS/ HONOURS

1. Visiting Professor, King’s College, London 1st Feb. 2002 to 18 Oct. 2002

2. Visiting Professor Department of Surgery, Mayo Clinic, Rochester, Minnesota

USA, 2009

3. Visiting Professor, Department of Surgery, Johns Hopkins Medical School, Baltimore, USA 2009

4. Visiting Professor, Department of Surgery, University of Pittsburg Medical

Center, Pittsburg, USA, 2009

5. Member Executive Committee Asian Society of Clinical Oncology, Japan

6. Member Scientific Committee 19th International Congress on Anti-Cancer Treatment Paris, France 2008

7. Member Task Force on Carcinoma Gallbladder of Indian Council of Medical Re-

search, New Delhi 2001

5

8. Member Committee on Soft Tissue Sarcoma National Guidelines for Cancer Treat-

ment of Indian Council of Medical Research, New Delhi, 2006

9. Member Research committee of King George’s Medical University from 2006

10. Associate Editor, Indian Association of Surgical Oncology, 2000 -2002

11. Editor, Indian Association of Surgical Oncology, 2003 – 2004

12. Secretary Indian Association of Surgical Oncology, 2007 -2008

13. Member Executive Committee - Indian Association of Surgical Oncology, 1998,

1999 -2000.

14. Member Editorial Board and Sectional Editor of Surgical Clinics of India

15. Examiner National Board of Examinations for the practical/clinical and viva-voce

examinations for the Diplomate of National Board in the subject of Surgical Oncol-

ogy.

16. Examiner for MCh Surgical Oncology to various institutions like AIIMS, New Delhi,

Gujarat Cancer Research Institute, Ahmedabad, Kidwai Memorial Institute of On-

cology, Bangalore, King George Medical University, Lucknow, etc.

17. Vice President, Indian Association Surgical Oncology – 2011.

18. Executive Committee Member Indian Society of Oncology 2011-2013

19. President Elect Indian Association of Surgical Oncology 2012

20. President Indian Association of Surgical Oncology 2013

21. Inspector National Board of Examinations, New Delhi for inspecting various medi-

cal institutions for training facilities in Surgical Oncology

22. Associate Editor Indian Journal of Surgical Oncology

23. Member Editorial Board International Journal of Surgical Oncology

6

24. Invitee as a Faculty to be one of the four Indian participants in the Cancer Discus-

sion Group to attend the ‘Advances in Healthcare through Affordable Technolo-

gies: A US-India Grand Challenge on December 6, 2011 at the India Habitat Cen-

tre, New Delhi. Organized by Department of Biotechnology.

25. Vice President UP Chapter Association of Surgeons of India 2012.

26. President Elect UP Chapter Association of Surgeons of India 2013.

27. President UP Chapter Association of Surgeons of India 2014.

28. Member of Scientific Committee Kobayashi Foundation, Japan

29. Hon. Secretary Indian Society of Oncology 2013-2017.

30. Editor in Chief, Annals of National Academy of Medical Sciences, New Delhi

31. Joint Editor, Indian Journal of Surgical Oncology, 2016 – continuing

32. Member National Coordination Committee of 1st Indian Cancer Congress, New Delhi, 2013

33. Member National Coordination Committee of 2nd Indian Cancer Congress, Bangalore, 2017

34. President Asian Clinical Oncology Society Meeting, New Delhi, 2016.

35. President Elect Indian Society of Oncology- 2017 -2019.

36. Council Member National Academy of Medical Sciences, New Delhi. 2017 – 2019.

37. Senate Member IIT, Jodhpur.

38. President Indian Society of Oncology, 2019-2021.

39. Chairperson National Academy of Medical Sciences (NAMS) Centre for Re-search in Medical Education at AIIMS, Jodhpur

40. Member CME Committee of National Academy of Medical Sciences, New Delhi.

7

41. Governing Body Member Govt. Institute of Medical Science, Greater Noida, UP

42. Member, Selection Committee for Director, Sanjay Gandhi Post Graduate In-stitute of Medical Sciences (SGPGIMS), Lucknow. (Appointed by Honorable Governor of UP)

43. Member, Selection Committee for Director, Super Speciality Paediatric Hos-pital & Post Graduate Teaching Institute, Noida

44. Mentor for Rajasthan and Gujarat states for establishment of RT-PCR labor-atories for diagnosis of COVID-19.

45. Chair of Bioethics Unit of the International Network of the UNESO Chair in Bioethics on 23rd March 2018.

46. Lead the Delegation visiting Sweden for collaboration under Ministry of Health and Social Affairs, Sweden & Ministry of Health, India, Stockholm, Sweden 11-14 June 2019.

47. Signatory of Letter of Intent between AIIMS Jodhpur and Public Health Agency

Sweden under the Memorandum of Understanding (MoU) between Ministry of Health and Social Affairs, Sweden and Ministry of Health, India on 12th June

2019.

48. Member, Governing Council of Indo-Swedish Health Care Innovation Center on 3rd December 2019.

49. Expert for brain storming consultation on training and capacity building in Cancer Epidemiology and Surveillance: ICMR-NCDIR, Bangalore on 7th Feb 2020.

50. Reviewer for Swiss National Science Foundation (SNSF) 51. Member, Advisory Committee of Indian Council of Medical Research (ICMR) 52. Member Regional Advisory Committee of American Association of Cancer Re-

search 2016 – 2018.

8

53. Convocation Address, on 8th Convocation Day Ceremony, Yenepoya Univer-sity, Mangalore, Karnataka, 26th October 2018.

54. Convocation Address, on 5th Convocation of National Institute of Pharmaceu-tical Education and Research (NIPER), Raebareli 23rd November 2019.

55. NASI (National Academy of Science, India) Plenary Lecture during 13th Utta-rakhand State Science & Technology Congress 2018-2019, 26-28 Feb, 2019, Dehradun, Uttarakhand.

FELLOWSHIPS

1. Varoon Mahajan Memorial Fellowship for Advanced training in Surgical Oncology

at Memorial Sloan Kettering Cancer Center, New York form 6 Aug 1996 to Nov.

1996

2. Clinical Exchange Programme at M.D Anderson Cancer Center, Houston Texas

USA, Nov 17 - 21 1997.

3. J. L. Rohatgi Travelling Fellowship of Association of Surgeons of India, U. P Chap-

ter 1998.

4. Visiting Guest Fellow at Cancer Institute Hospital, Tokyo, Japan 25 June 2000 to

22 July 2000.

5. Commonwealth Fellowship as at King’s College, London 1st Feb. 2002 to 18

Oct. 2002.

6. Varoon Mahajan Memorial Fellowship for Advanced training in Surgical Oncology

at Memorial Sloan Kettering Cancer Center, New York from 18 April 2005 to 10

July 2005.

7. Fellowship at Memorial Sloan Kettering Cancer Center, New York 9 July to 26 July

2007

9

8. Fellow of Royal College of Surgeons of England ad eundem – 2008. The Fel-

lowship ad eundem is awarded to a selected few surgeons in the world in recog-

nition of their scientific contribution.

9. International Guest Scholar of American College of Surgeons for 2009.

10. Fellow of American College of Surgeons, USA 2010.

11. Fellow of National Academy of Medical Sciences, New Delhi - 2011.

12. Fellow of Royal College of Surgeons of Glasgow ad eundem – 2013. The Fel-

lowship ad eundem is awarded to a selected few surgeons in the world in recog-

nition of their scientific contribution.

13. Fellow of National Science Academy, India 2016 – in recognition of research

contribution to science. Very few surgeons are fellows.

14. Honorary Member of British Association of Surgical Oncology. – Prestigious

society for the contribution to medicine as a teacher and academician.

Reviewer for International and National Journals

Reviewer for 15 International and 4 National Journals

Lancet, Surgical Oncology, BMC Surgery, BMC Cancer, World Journal of Surgical Oncology, Annals of Oncology, Head & Neck, Anti Cancer Drugs, Metabolism, Clin-ical and Experimental Ophthalmology, Digestive and Liver Disease, International Journal of Surgical Oncology, World Journal of Surgery, Annals of Surgical Oncol-ogy, Diagnostic Cytopathology,

Indian Journal of Medical and Pediatric Oncology, Indian Journal of Surgery, Indian Journal

of Plastic Surgery, Indian Journal of Surgical Oncology

PUBLICATIONS - CHAPTER IN BOOKS, PAPERS, ABSTRACTS

CHAPTER IN BOOKS

10

1. NC Misra, S Misra, S Bhattacharya. Classification of tumours: Current concepts. In

Principles of Cancer Surgery and Chemotherapy. Editors A.K. Sharma and S.B.

Rizyal. Publisher - WHO & Nepal Cancer Relief Society, Kathmandu, Nepal, 20-28,

1988.

2. NC Misra, S Misra, A Chaturvedi. Carcinoma of the Gallbladder. – “Recent Ad-vances in Surgery -20. Editors - C.D. Johnson, I Taylor. Publisher -Churchill Liv-

ingstone, London, 69 -87, 1997.

3. NC Misra, A Chaturvedi, S Misra. Locally Advanced Breast Cancer. Recent Ad-vances in Surgery 6. Editor Roshan Lal Gupta. Publisher- Jaypee Brothers, New

Delhi, 248 - 259, 1998.

4. NC Misra, S Misra, A Chaturvedi. Epidemiology, Etiology and New Perspectives in

Carcinoma Gallbladder. In Progress in Surgery. Editor K. S. Shekar. Publisher

Adarsh Printers, Bangalore. 121 - 142, 1997.

5. R Kumar, S Misra, A Chaturvedi, ID Sharma. 'Screening for Breast Cancer'. In

'Consensus on Breast Cancer' Editor- SM Bose, Publisher Relume Printec, Chan-

digarh, 15-24, 2000.

6. S Misra, A Chaturvedi, NC Misra. Oral Carcinoma. In ‘Recent Advances in Sur-gery – 25’. Editors - C. D Johnson, I Taylor. Publisher – Royal Society of Medicine

Press, London 71-86; 2002.

7. Misra S, Chaturvedi A. ‘Adult Soft Tissue Sarcomas of Extremities’ Book Chapter ‘Lectures by Masters of Surgery’. Ed. Sonkar A A. Department of Surgery, CSM

Medical University, Lucknow, pg. 70-79, 2008.

8. Misra S, Chaturvedi A. ‘Multimodality Treatment and Limb Conservation in Adult

Soft Tissue Sarcomas of Extremities’. Handbook of Oncology V th. Edition Eds.

Ganguly M, Kapoor S. pg. 126-131, New Delhi.

9. Misra S, Chaturvedi A. ‘Soft tissue Sarcoma’ - Chapter in Book ‘Common cancers

in India- Guidelines’ Published by RR Hospital New Delhi, 2008

11

10. Misra S, Chaturvedi A, Management of Gingivobuccal Complex Cancer in Proceed-

ings of the Asia-Pacific Congress on Oral Cancer in Conjunction with the 12th Annual

Meeting of Taiwan Cooperative Group (TCOG), National Institute of Cancer Re-

search, National Health Research Institute, Taiwan, 2008

11. Misra Sanjeev, Chaturvedi Arun, ‘Management of Adult Extremity Soft Tissue Sar-

comas’ - Book Chapter ‘Recent Advances in Surgery - 32’. Eds. CD Johnson, I

Taylor. The Royal Society of Medicine Press Ltd., London, Pg. 39-56, 2009.

12. Misra S, Chaturvedi A. Management of Mandible in Gingivobuccal cancers. Pro-

ceedings 1st Congress of Asian Society of Head and Neck Oncology (ASHNO),

Taiwan Head and Neck Society, Asian Society of Head and Neck Oncology, Taipei,

Taiwan 2009

13. Misra S, Kumar V, Singhal A. Breast Cancer. Chapter-ASI Textbook of Surgery

2nd edition, Editor in Chief Dr AA Hai, Publisher Jaypee’s, New Delhi.

14. Misra S, Singhal A. Cancer Problem in India – Cancer control from a Developing

Country Perspective. In Recent Advances of Cancer in Asian Countries. Editors S

Saji, T Taguchi, K Yoshida, S Osada. Publisher Cancer and Chemotherapy Pub-

lishers Company, Tokyo Japan pg 16 – 25, 2010.

15. Misra S, Chaturvedi A. Management of Retroperitoneal Sarcoma. In ‘Recent Ad-vances in Surgery – 34’. Editors - C. D Johnson, I Taylor. Publisher – Jaypee

Brothers Medical Publishers, New Delhi 205-220; 2011.

16. Misra S. History of Development of Surgical Oncology in India. In History of Surgery,

Milestones & Developments in Surgery in India since Independence. Editor – S.P.

Kaushik. Publisher – Divyesh Arvind Kothari for Paras Medical Publisher, Hydera-

bad 140-144, 2013.

17. Misra S, Agarwal A, Chaturvedi A. ‘Management of Hepatocellular Carcinoma’ in

‘Recent Advances in Surgery – 36’. Editors - C. D Johnson, I Taylor. Publisher -

Jaypee Brothers Medical Publishers, New Delhi 82-94; 2014.

12

18. Kumar V, Misra S. Surgery in Geriatric Malignancy in Textbook of Geriatric Medicine

– Editor in Chief - Pratap Sanchetee, Publisher Paras Medical Publisher, Hydera-

bad, 695-697, 2014.

19. Misra S, Agarwal A, Chaturvedi A. ‘Salivary Gland Tumours’ in ‘Recent Advances in Surgery – 38’. Editors – Michael Douek, I Taylor. Publisher - Jaypee Brothers

Medical Publishers, New Delhi; 2016.

20. Agarwal A, Chaturvedi A, Sanjeev Misra. ‘Oral Cancer’ in ‘Surgical Oncology Theory and Multidisciplinary Practice-Second Edition’. Editors – Graeme

Poston, Lynda Wyld, Riccardo A Audisio. Publisher – CRC Press Taylor & Francis

Group, 165-172, 2016.

21. Chaturvedi A, Agarwal A, Sanjeev Misra. ‘Salivary Gland Tumors’ in ‘Surgical On-cology Theory and Multidisciplinary Practice-Second Edition’. Editors –

Graeme Poston, Lynda Wyld, Riccardo A Audisio. Publisher – CRC Press Taylor &

Francis Group, 173-178, 2016.

22. Gupta S, Agarwal A, Sanjeev Misra. ‘Paranasal Sinus Cancers’ in ‘Surgical On-cology Theory and Multidisciplinary Practice-Second Edition’. Editors –

Graeme Poston, Lynda Wyld, Riccardo A Audisio. Publisher – CRC Press Taylor &

Francis Group, 179-184, 2016.

23. Goyal A, Gupta S, Sanjeev Misra. ‘Skull Base Tumours’ in ‘Surgical Oncology Theory and Multidisciplinary Practice-Second Edition’. Editors – Graeme Poston, Lynda Wyld, Riccardo A Audisio. Publisher – CRC Press Taylor & Francis Group, 185-190, 2016.

24. Dwivedi S, Chikara G, Samdariya S, Goel A, Pandey RK, Pareek P, Sharma P , Khattri S, Pant KK , S Misra. Applied Molecular Biotechnology: The Next Generation of Genetic Engineering. Khan S, Barh D,Khan IA (eds), Molecular biotechnology for diagnostics. CRC Taylor Francis ISBN 9781498714815 - CAT# K25311,pp-303-33 (2016).

25. Dwivedi S, Purohit P, Mittal Y, Gupta G, Goel A, Verma RC, Khattri S, Sharma P, Misra S, Pant KK. Genetic Engineering: Towards Gene Therapy and Molecular Medicine. In: Omics Technologies and Bio-Engineering. Elsevier; 2018. p. 507–32.

13

26. Misra S, Agarwal A, Chaturvedi A. Salivary Gland Tumors. In: Recent Advances in Surgery—38. Jaypee Brothers Medical Publishers (P) Ltd.; 2018. p. 127–127.

27. Dwivedi S, Purohit P, Misra R, Vishnoi JR, Goel A, Pareek P, Khattri S, Sharma P, Misra S, Pant KK. Precision medicine in ovarian carcinoma. In: Precision Medi-cine in Cancers and Non-Communicable Diseases. Ed. Boca Raton, FL: CRC Press, 2019.: CRC Press; 2018. p. 145–71.

28. Shukla KK, Sankanagoudar S, Sanganeria BS, Pareek P, Ram J, Misra S, Sharma P. Recent Advances in Molecular Diagnostic Approaches for Cancer. In: Molecular Diagnostics in Cancer Patients. Singapore: Springer Singapore; 2019. P.1–9.

29. Dwivedi S, Misra R, Purohit P, Vishnoi JR, Pareek P, Goel A, Khattri S, Sharma P, Pant KK, Misra S. Molecular Diagnosis in Ovarian Carcinoma. In: Molecular Di-agnostics in Cancer Patients. Singapore: Springer Singapore; 2019. p. 323–41.

30. Dwivedi S, Purohit P, Misra R, Lingeswaran M, Vishnoi JR, Pareek P, Misra S. Application of Single-Cell Omics in Breast Cancer. In: Single-Cell Omics. Else-vier; 2019. p. 69–103.

31. Dwivedi S, Purohit P, Misra R, Lingeswaram M, Vishnoi JR, Pareek P, Sharma P, Misra S. Applications of single omics in Breast Cancer. Barh D, Azevedo V (eds) Single Cell Omics. Technological Advances and Applications Vol. Academic Press, Elsevier. Paperback ISBN 9780128175323; e Book ISBN 97801281753330, pp 69-103 (2019)

BOOK PUBLISHED

1. Shukla KK, Sharma P, Misra S, Editors. Molecular Diagnostics in Cancer Pa-tients. Springer Singapore; 2019

PAPER PUBLISHED

1. S Misra, Ashoka Sahai. A morphological study of superior mesenteric artery of

Indians. Journals of Anatomical Sciences, 7: XI, 1985.

14

2. SK Agarwal, KD Verma, S Misra. New Normal values of thyroid function tests after

Iodized Salt prophylaxis in North Indian Population. Surgery (Journal of U.P.

Chapter of Association of Surgeons of India) 2(5), 61-62, 1991

3. A Chaturvedi, S Misra. Chemotherapeutic Strategies in Head and Neck Cancer.

Satellite (An official publication of the UP-state branch of the Indian Dental Asso-

ciation) 1-2, 15-19, 1995.

4. DC Doval, CR Rao, S Misra, L Devi, V Srinivas, M Chandrashekar, PP Bapsy.

Isolated Granulocytic Sarcoma of Breast. Annals of Oncology 7, 424-425 1996.

5. DC Doval, CR Rao, KS Sabitha, M Vijayakumar, S Misra, K Mani, PP Bapsy, SV

Kumaraswamy. Malignant melanomas of the Oral Cavity. Report of fourteen cases

from a Regional Cancer Centre. European Journal of Surgical Oncology 22:245-249, 1996.

6. ID Sharma, S Misra, Rajeev Kumar, Ranu Tandon. Benign Breast Diseases in

males. Annals of Endocrine Surgery (Indian Journal of Endocrine Surgery) 1,

49-57, 1996.

7. NC Misra, S Misra. Perspectives in Oncology by 2000 A.D - Surgery (Journal of

U.P. Chapter of Association of Surgeons of India). 1(2), 49-56, 1996.

8. DC Doval, RV Kumar, KS Sabitha, S Misra, M Vijayakumar, P Hedge, PP Bapsy,

K Mani, AM Shenoy, SV Kumaraswamy. Osteosarcoma of Jaw Bones. British Journal of Oral and Maxillofacial Surgery 35: 357-362, 1997.

9. NC Misra, A Chaturvedi, S Misra, R Tandon, R Kumar, R Kant. Multimodal Ther-

apy with Special Reference to Neo-Adjuvant Chemotherapy (NAC) in advanced

T3 and T4 Oral Cancer in India. Japanese Journal of Cancer Chemotherapy Vol 24, Suppl 1,150: 1997.

10. S Misra, PK Agarwal, RK Tandon, AK Wakhlu, NC Misra. Bladder Teratoma - A

case report and review of literature. Indian Journal of Cancer 31; 20- 21, 1997.

11. S Misra, Arun Chaturvedi, NC Misra. Carcinoma gallbladder presenting with skel-

etal metastases. Indian Journal of Gastroenterology 16: 74, 1997.

15

12. NC Misra, S Misra, A Chaturvedi. Epidemiology, Etiology and New Perspective in

Carcinoma Gallbladder. Indian J Surgery 60: 167-176, 1998.

13. DC Doval, C Rama Rao, R Acharya, S Misra, L Narasimha, M Chandrashekhar,

PP Bapsy, Pericardial mesotheliomas: A report of two cases. Indian J of Medical and Paediatric Oncology. 19(1), 13-18, 1998.

14. Ranjana Singh, RK Singh, AA Mahdi, S Misra, SP Rai, D Singh, G Cornelissen, F

Halberg. Studies on circadian periodicity of urinary corticosteroids in carcinoma of

the breast. In Vivo 12: 69-74, 1998

15. PS Prabhakaran, S Misra, V Kannan, M Chandrashekar, M Vijayakumar, KV Vee-

rendrakumar, N Anantha. Sacral Chordomas: a 10 - year study. Australas Radiol 42: 1, 42-46, 1998.

16. NC Misra, S Misra, A Chaturvedi. 'Cancer Surgery for General Surgeons'. Sur-gery. 10 (14), 1-5, 2000.

17. Misra S. Biliary tract cancer - Gallbladder Cancer. ‘Mitomycin C 2000’ Ed. Gianni

Beretta, Publisher Edizioni Minerva Medica 15:72-73, 2000.

18. S Misra, A Chaturvedi, MM Goel, AN Srivastava, R Mehrotra, ID Sharma, NC

Misra. Overexpression of p53 protein in gallbladder carcinoma in North India. Eu-ropean Journal of Surgical Oncology 26: 164-167, 2000.

19. A Misra, S Misra, A Chaturvedi, PK Srivastava. Osteosarcoma with Orbital Metas-

tasis – A Case Report. British Journal of Ophthalmology 85; 11:1387-1388,

2001.

20. NC Misra, S Misra. Carcinoma of the Penis. Proceedings of the XI International

Congress on Anticancer Treatment. Feb 6-9, 2001, Paris, France

21. A Misra, S Misra, A Chaturvedi, P K Srivastava. Orbital Metastasis from Gall Blad-

der Carcinoma. British Journal of Radiology 75: 72-73, 2002.

22. A Wakhlu, S Misra, RK Tandon, AK Wakhlu. Sacrococcygeal teratoma. Pediatr Surg Int 18: 384- 387, 2002.

16

23. S Misra, A Chaturvedi, NC Misra, ID Sharma. Carcinoma of the gallbladder. Lan-cet Oncology 4: 167-176, 2003.

24. S Misra, NC Misra, A Chaturvedi, ID Sharma. Carcinoma Gallbladder–Radical

Surgery and Chemotherapy Prospectus study of 657 patients’ Cancer Research and Treatment 35 (Suppl): 56-57, 2003.

25. S Misra, NC Misra, A Chaturvedi Technique and results of Radical cholecys-tectomy. Proceedings 7th Biennial Congress of Asian Society of Hepato-Biliary

Pancreatic Surgery, August 28-31, 2003.

26. S Misra, NC Misra, A Chaturvedi Chemotherapy for Carcinoma of the Gallblad-der. Proceedings 7th Biennial Congress of Asian Society of Hepato-Biliary Pancre-

atic Surgery, August 28-31, 2003.

27. S Misra, NC Misra. Management of ovarian cancer. FOGSI Focus 2003, Preven-tive Oncology, Emerging Concepts of Cancer Care. 24-25, 2003.

28. S Misra, A Chaturvedi, NC Misra. Penile carcinoma: a challenge for the develop-

ing world’. Lancet Oncology 5: 240-247, 2004.

29. S Misra, A Chaturvedi, NC Misra. Gemcitabine(G) plus cisplatin (C) in advanced

carcinoma gallbladder - A large single center experience. J Clin Oncol 2005, 23:341, Abstract 4136.

30. Misra S, Chaturvedi A, Misra N C. Gallbladder Cancer. Current Treatment Op-tions in Gastroenterology 9: 95 – 106, 2006.

31. S Misra, A Chaturvedi, NC Misra, Carcinoma Gallbladder – from Nihilism to Opti-

mism. Proceedings 18th International Conference on Anti Cancer Treatment, Paris,

Feb 6-9, 2007, EL – 52, Pg. 196-199.

32. S Misra, A Chaturvedi, NC Misra. Gallbladder cancer – Surgical Management. In-dian J Med Paed Oncology Vol. 28, 46-53, 2007.

33. Misra S, Singhal A. Treatment Choices in Prostate Cancer. Physician’s Digest

2008; 17 (4): 16-23.

17

34. Husain N, Chaturvedi A, Misra S. Tuberculosis of the Parotid Gland Mimicking

Neoplasia. Infectious Diseases in Clinical Practice (IDCP). 2008 July; 16(4):261-

263.

35. Sodhi K, Chaturvedi A, Misra S, Kumar V, Athar M, Srivastava M, Husain N. Mer-

kel cell carcinoma, report of two patients. The Internet Journal of Oncology. Vol-

ume 5, 2008, Number 1.

36. Misra S, Chaturvedi A, Misra NC. Management of gingivobuccal complex cancer. Ann R Coll Surg Engl 2008; 90: 546–553

37. Chaudhary A, Wakhlu A, Mittal N, Misra S, Mehrotra D, Wakhlu AK. Melanotic

Neuroectodermal Tumor of Infancy: 2 Decades of Clinical Experience With 18

Patients, Journal Oral and Maxillofacial Surgery 2009; 67(1): 47-51.

38. Misra S. A Tribute to Prof N C Misra – Pioneer and Leader in Oncology. Indian Journal of Surgical Oncology 2011, 2(3): 218-220.

39. Bansal C, Singh US, Misra S, Sharma KL, Tiwari V, Srivastava AN. Comparative

evaluation of the modified Scarff-Bloom-Richardson grading system on breast car-

cinoma aspirates and histopathology. Cytojournal. 2012; 9:4. Epub 2012 Jan

40. Srivastava A, Sharma KL, Srivastava N, Misra S, Mittal B. Significant role of es-

trogen and progesterone receptor sequence variants in gallbladder cancer predis-

position: a multi-analytical strategy. PLoS One. 2012;7 (7):e40162. Epub 2012 Jul

10.

41. Sharma KL, Misra S, Kumar A, Mittal B. Higher risk of matrix metalloproteinase

(MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants

to gallbladder cancer. Liver Int. 2012 Sep;32(8):1278-86.

42. Kumar V, Misra S, Chaturvedi A. Retroperitoneal Sarcomas- A Challenging Prob-

lem. Indian Journal of Surgical Oncology 2012, 3 (3): 215-221.

43. Gupta S, Misra S. Rare Presentation of Malignant Porcelain Gallbladder with

Intrahepatic Ductal Calcification and Surgical Obstructive Jaundice. Indian Jour-nal of Surgical Oncology 2012; 3 (1):44-46.

18

44. Rathanaswamy S, Misra S, Kumar V, Chintamani, Jaipalreddy P, Agarwal A.

Incidentally Detected Gallbladder Cancer. The Controversies and Algorithmic

Approach to Management. Indian Journal of Surgery 2012, 74(3): 248-254.

45. Rai R, Sharma KL, Tiwari S, Misra S, Kumar A, Mittal B. DCC (deleted in colorectal

carcinoma) gene variants confer increased susceptibility to gallbladder cancer

(Ref. No.: Gene-D-12-01446). Gene. 2013 Apr 15;518(2):303-9

46. Pahwa HS, Misra S, Kumar A, Kumar V, Agarwal A, Srivastava R. Video Endo-

scopic Inguinal Lymphadenectomy (VEIL) -a prospective critical perioperative as-

sessment of feasibility and morbidity with points of technique in penile carcinoma.

World J Surg Oncol. 2013 Feb 22;11(1):42.

47. Rai R, Sharma KL, Misra S, Kumar A, Mittal B. PSCA gene variants (rs2294008

and rs2978974) confer increased susceptibility of gallbladder carcinoma in fe-

males. Gene. 2013 Nov 10;530(2):172-7.

48. Sharma KL, Umar M, Pandey M, Misra S, Kumar A, Kumar V, Mittal B. Association

of Potentially Functional Genetic Variants of PLCE1 with Gallbladder Cancer Sus-

ceptibility in North Indian Population. J Gastrointest Cancer. 2013 Aug 22.

49. Sharma KL, Misra S, Kumar A, Mittal B. Association of liver X receptors (LXRs)

genetic variants to gallbladder cancer susceptibility. Tumour Biol. 2013 Jul 11.

50. Pogal J, Kumar V, Husain N, Misra S. A unique case of two primaries: carcinoma

breast with carcinoma gallbladder. BMJ Case Rep. 2013 May 27;2013.

doi:10.1136/bcr-2013-009243.

51. Singh, K., Sharma, B., Misra, S., Bajaj, J. S. (2013). Determination of Satisfaction

Index as a tool in evaluation of CME Program. Ann Natl Acad Med Sci (India). 49

(3&4): 185-193.

52. Sharma KL, Yadav A, Gupta A, Tulsayan S, Kumar V, Misra S, Kumar A, Mittal B.

Association of genetic variants of cancer stem cell gene CD44 haplotypes with

gallbladder cancer susceptibility in North Indian population. Tumour Biol. 2014

Mar;35(3):2583-9. doi: 10.1007/s13277-013-1340-8.

19

53. Sharma KL, Agarwal A, Misra S, Kumar V, Kumar A, Mittal B, Association of ge-

netic Variants of Xenobiotic and Estrogen metabolism pathway genes (CYP1A1

and CYP1B1) with Gallbladder Cancer Susceptibility Tumour Biol. 2014 Feb

18 [PMID:24535777]

54. Rai R, Sharma KL, Misra S, Kumar A, Mittal B, "Role of Adrenergic Receptor gene

polymorphisms in Gallbladder Cancer Susceptibility in a North Indian Population"

J Cancer Res Clin Oncol. 2014 Feb 21. [PMID: 24556804]

55. Rai R, Sharma KL, Sharma S, Misra S, Kumar A, Mittal B. Death Receptor (DR4)

Haplotypes Are Associated with Increased Susceptibility of Gallbladder Carcinoma

in North Indian Population. PLoS One. 2014 Feb 28;9(2):e90264.

56. Bansal C, Sharma KL, Misra S, Srivastava AN, Mittal B, Singh US. Common ge-

netic variants in pre-microRNAs and risk of breast cancer in the North Indian pop-

ulation. Ecancermedicalscience. 2014 Oct 20;8:473. doi: 10.3332/ ecancer.

2014.473. eCollection 2014

57. Khan H, Gupta S, Husain N, Misra S, Singh N, Negi MP. Prognostics of Cyclin-D1

expression with chemoradiation response in patients of locally advanced oral

squamous cell carcinoma. J Cancer Res Ther. 2014 Apr-Jun;10(2):258-64.

58. Sameer G, Naseem A, Vijay K, Sanjeev M, Jaswant J, Vadakkanchery AS. Skel-

etal metastasis in gallbladder cancer from a high-volume tertiary care center of

north India: a series of rare occurrence. J Gastrointest Cancer. 2015

Mar;46(1):36-41.

59. Singh, K., Thanvi, V., Misra, S., Bhansali, S., & Bajaj, J. S. (2015). Comparative

effectiveness of non-print media and live CME. Ann Natl Acad Med Sci (India).

51 (1&2) : 20-29.

60. Singh, K., Sharma, B., Misra, S., & Bajaj, J. S. (2015). Exploring the scope of sleep

medicine in current medical teaching and utility of CD Based Learning Resource

Material. Ann Natl Acad Med Sci (India), 51(1 & 2): 30-38.

20

61. Singh, K., Misra, S., Bajaj, J.S. (2015). Poster presentations: New initiative at

NAMSCON 2013 at AIIMS Jodhpur. Ann Natl Acad Med Sci (India), 51(1 & 2):

54-56.

62. Singh, K., Gupta, N., Misra, S., Bajaj, J.S. (2015). Optimizing the effectiveness of

CME Program: NAMS Experience. Ann Natl Acad Med Sci (India), 51 (1 &2): 6-

12.

63. Singh MP, Misra S, Rathanaswamy SP, Gupta S, Tewari BN, Bhatt ML, Kumar V.

Clinical profile and epidemiological factors of oral cancer patients from North India.

Natl J Maxillofac Surg. 2015 Jan-Jun;6(1):21-4.

64. Tewari BN, Singh Baghel K, Tripathi C, Dubey P, Bhatt ML, Kumar V, Mati Goel M,

Singh Negi MP, Misra S. A study on local expression of NF-κB, CCL2 and their

involvement in intratumoral macrophage infiltration in breast cancer. Cell Mol Biol (Noisy-le-grand). 2016 Feb 29;62(2):116-25.

65. Singh MP, Kumar V, Agarwal A, Kumar R, Bhatt ML, Misra S. Clinico-epidemio-

logical study of oral squamous cell carcinoma: A tertiary care centre study in North

India. J Oral Biol Craniofac Res. 2016 Jan-Apr;6(1):31-4.

66. Yadav A, Gupta A, Yadav S, Rastogi N, Agrawal S, Kumar A, Kumar V, Misra S, Mittal B. Association of Wnt signaling pathway genetic variants in gallbladder can-

cer susceptibility and survival. Tumour Biol. 2015 Dec 29. [Epub ahead of print]

67. Khan H, Gupta S, Husain N, Misra S, Mps N, Jamal N, Ghatak A. Correlation

between expressions of Cyclin-D1, EGFR and p53 with chemoradiation response

in patients of locally advanced oral squamous cell carcinoma. BBA Clin. 2014

Nov 21;3:11-7.

68. Rai R, Kim JJ, Misra S, Kumar A, Mittal B. A Multiple Interaction Analysis Reveals

ADRB3 as a Potential Candidate for Gallbladder Cancer Predisposition via a Com-

plex Interaction with Other Candidate Gene Variations. Int J Mol Sci. 2015 Nov

25;16(12):28038-49.

21

69. Nebhinani N, Ghatak S, Singh K, Misra S, Bhagat OL, Garg R. Effect of Person-

ality Development Program for Medical and Nursing Students: A Pilot Study. Ann Natl Acad Med Sci (India) 2015; 51: 13-19.

70. Gupta S, Kori C, Kumar V, Misra S, Akhtar N. Epidemiological Study of Gallblad-

der Cancer Patients from North Indian Gangetic Planes-a High-Volume Centre's

Experience. J Gastrointest Cancer. 2016 Mar;47(1):27-35.

71. Misra S. Health care in the era of innovations. Ann Natl Acad Med Sci (India)

2016; 52(1): i-ii,

72. Misra S. Medical Discoveries: From benchtop to bedside. Ann Natl Acad Med Sci (India) 2016; 52(2): i-ii,

73. Singh V, Husain N, Akhtar N, Kumar V, Tewari S, Mishra S, Misra S, Khan MY. Do

Human Papilloma Viruses Play Any Role in Oral Squamous Cell Carcinoma in

North Indians? Asian Pac J Cancer Prev. 2015;16(16):7077-84.

74. Misra S, Agarwal A, Chaturvedi A. Cancer surgery: an Indian-Asian perspective.

Lancet Oncol. 2015 Sep;16(11):1189-90.

75. Gupta A, Sharma A, Yadav A, Rastogi N, Agrawal S, Kumar A, Kumar V, Misra S, Mittal B. Evaluation of miR-27a, miR-181a, and miR-570 genetic variants with

gallbladder cancer susceptibility and treatment outcome in a North Indian popu-

lation. Mol Diagn Ther. 2015 Oct;19(5):317-27.

76. Dwivedi S, Goel A, Mandhani A, Khattri S, Sharma P, Misra S, Pant KK. Func-

tional genetic variability at promoters of pro-(IL-18) and anti-(IL-10) inflammatory

affects their mRNA expression and survival in prostate carcinoma patients: Five

year follow-up study. Prostate. 2015 Nov;75(15):1737-46.

77. Dwivedi S, Singh S, Goel A, Khattri S, Mandhani A, Sharma P, Misra S, Pant KK.

Pro-(IL-18) and Anti-(IL-10) Inflammatory Promoter Genetic Variants (Intrinsic

Factors) with Tobacco Exposure (Extrinsic Factors) May Influence Susceptibility

and Severity of Prostate Carcinoma: A Prospective Study. Asian Pac J Cancer Prev. 2015;16(8):3173-81.

22

78. Dwivedi S, Goel A, Khattri S, Mandhani A, Sharma P, Misra S, Pant KK. Genetic

variability at promoters of IL-18 (pro-) and IL-10 (anti-) inflammatory gene affects

susceptibility and their circulating serum levels: An explorative study of prostate

cancer patients in North Indian populations. Cytokine. 2015 Jul;74(1):117-22.

79. Yadav A, Gupta A, Yadav S, Rastogi N, Agrawal S, Kumar A, Kumar V, Misra S, Mittal B. Association of Wnt signaling pathway genetic variants in gallbladder can-

cer susceptibility and survival. Tumour Biol. 2016 Jun;37(6):8083-95.

80. Noh DY, Roh JK, Kim YH, Yoshida K, Baba H, Samson-Fernando MC, Misra S, Aziz Z, Umbas R, P Singh Y, Shu Kam Mok T, Yang HK, Akaza H. Symposium:

"Oncology Leadership in Asia". Cancer Res Treat. 2017 Apr;49 (2):283-291.

81. Shukla KK, Misra S, Pareek P, Mishra V, Singhal B, Sharma P. Recent scenario

of microRNA as diagnostic and prognostic biomarkers of prostate cancer. Urol Oncol. 2017 Mar; 35(3):92-101.

82. Misra S. Editorial. Ann Natl Acad Med Sci (India) 2017; 53(1): i-iii,

83. Misra S, Singh K. National Health Policy 2017 (NHP2017): Biomedical Research

and Technology. Ann Natl Acad Med Sci (India), 2017; 53(2): i-iii,

84. Baghel KS, Tewari BN, Shrivastava R, Malik SA, Lone MU, Jain NK, Tripathi C,

Kanchan RK, Dixit S, Singh K, Mitra K, Negi MP, Srivastava M, Misra S, Bhatt ML,

Bhadauria S. Macrophages promote matrix protrusive and invasive function of

breast cancer cells via MIP-1β dependent upregulation of MYO3A gene in breast

cancer cells. Oncoimmunology. 2016 Jul 15;5(7):e1196299.

85. Bansal C, Pujani M, Misra S, Srivastava AN, Singh US. Circulating Tumor Cells in

Breast Cancer: Correlation with Clinicopathological Parameters, Hormone Profile

and MicroRNA Polymorphisms. Turk Patoloji Derg. 2016;32(3):148-57.

86. Yadav DK, Saloni, Sharma P, Misra S, Singh H, Mancera RL, Kim K, Jang C, Kim

MH, Pérez-Sánchez H, Choi EH, Kumar S. Studies of the benzopyran class of

selective COX-2 inhibitors using 3D-QSAR and molecular docking. Arch Pharm Res. 2017 Aug 18. doi: 10.1007/s12272-017-0945-7.

23

87. Poornima B, Siva B, Venkanna A, Shankaraiah G, Jain N, Yadav DK, Misra S, Babu KS. Novel Gomisin B analogues as potential cytotoxic agents: Design, syn-

thesis, biological evaluation and docking studies. Eur J Med Chem. 2017 Oct

20;139: 441-453.

88. Gupta A, Ahmed P, Durgapal P, Kala P, RaoS, Pasricha R, Misra S. Neuroendo-

crine Carcinoma of Gall Bladder: A Rare Presentation with Review of Literature.

Gulf J Oncology. 2017 May;1(24):51-54.

89. Yadav DK, Kumar S, Saloni, Singh H, Kim MH, Sharma P, Misra S, Khan F. Mo-

lecular docking, QSAR and ADMET studies of with anolide analogs against breast

cancer. Drug Des Devel Ther. 2017 Jun 22;11:1859-1870.

90. Yadav DK, Rai R, Kumar N, Singh S, Misra S, Sharma P, Shaw P, Pérez-Sánchez

H, Mancera RL, Choi EH, Kim MH, Pratap R. New arylated benzo[h]quinolines

induce anti-cancer activity by oxidative stress-mediated DNA damage. Sci Rep.

2016 Dec 6;6:38128.

91. Shukla KK, Misra S, Pareek P, Mishra V, Singhal B, Sharma P. Recent scenario

of microRNA as diagnostic and prognostic biomarkers of prostate cancer. Urol Oncol. 2017 Mar;35(3):92–101.

92. Dwivedi S, Purohit P, Misra R, Pareek P, Goel A, Khattri S, Pant KK, Misra S,

Sharma P. Diseases and Molecular Diagnostics: A Step Closer to Precision Med-

icine. Vol. 32, Indian J Clin Biochem: 2017. p. 374–98.

93. Lakshmanan M, Gupta S, Kumar V, Akhtar N, Chaturvedi A, Misra S, Jain K, Garg

S. Germ Cell Tumor Ovary: An Institutional Experience of Treatment and Survival

Outcomes. Indian J Surg Oncol. 2018 Jun;9(2):215–9.

94. Misra S. From the Desk of the Editor. Vol. 9, Indian J Surg Oncol.. 2018. p. 295.

95. Neyaz A, Husain N, Gupta S, Kumari S, Arora A, Awasthi NP, Malhotra KP, Misra

S. Investigation of targetable predictive and prognostic markers in gallbladder car-

cinoma. J Gastrointest Oncol. 2018 Feb;9(1):111–25.

24

96. Sharma V, Jaiswal PK, Saran M, Yadav DK, Saloni, Mathur M, Swami AK, Misra

S, Kim MH, Chaudhary S. Discovery of C-3 Tethered 2-oxo-benzo [1,4] oxazines

as Potent Antioxidants: Bio-Inspired Based Design, Synthesis, Biological Evalua-

tion, Cytotoxic, and in Silico Molecular Docking Studies. Front Chem. 2018; 6:56.

97. Yadav DK, Kumar S, Choi E-H, Sharma P, Misra S, Kim M-H. Insight into the Mo-

lecular Dynamic Simulation Studies of Reactive Oxygen Species in Native Skin

Membrane. Front Pharmacol. 2018; 9:644.

98. Yadav DK, Kumar S, Saloni, Misra S, Yadav L, Teli M, Sharma P, Chaudhary S,

Kumar N, Choi EH, Kim HS, Kim MH. Molecular Insights into the Interaction of

RONS and Thieno[3,2-c] pyran Analogs with SIRT6/COX-2: A Molecular Dynamics

Study. Sci Rep. 2018 Mar;8(1):4777.

99. Misra S, Singh K. Translating Research into Clinical Practice Skills. Ann Natl Acad Med Sci (India) 2018;54 (1): i-iii

100. 12. Singh K, Misra S. Ensuring Healthy Community: Tapping them Young. Ann Natl Acad Med Sci (India) 2018;54 (4): i-iii

101. Yadav DK, Saloni, Sharma P, Misra S, Singh H, Mancera RL, Kim K, Jang C, Kim

MH, Pérez-Sánchez H, Choi EH, Kumar S. Studies of the benzopyran class of

selective COX-2 inhibitors using 3D-QSAR and molecular docking. Arch Pharm Res. 2018 Dec;41(12):1178–89.

102. Chaturvedi A, Husain N, Misra S, Kumar V, Gupta S, Akhtar N, Lakshmanan M,

Garg S, Arora A, Jain K. Validation of the Brandwein Gensler Risk Model in Pa-

tients of Oral Cavity Squamous Cell Carcinoma in North India. Head Neck Pathol. 2019 Sep; (Online first).

103. Misra S. Quality Improvement in Medical Education. Ann Natl Acad Med Sci (In-

dia) 2019; 55:117–118

104. Dwivedi S, Purohit P, Misra R, Lingeswaran M, Vishnoi JR, Pareek P, Misra S,

Sharma P. Single Cell Omics of Breast Cancer: An Update on Characterization

and Diagnosis. Indian J Clin Biochem. 2019 Jan;34(1):3–18.

25

105. Dwivedi S, Purohit P, Misra R, Pareek P, Vishnoi JR, Misra S, Sharma P. Methods

for Isolation of High Quality and Quantity of miRNA and Single Cell Suspension for

Flow-Cytometry from Breast Cancer Tissue: A Comparative Analysis. Indian J Clin Biochem. 2019 Jan;34(1):39–44.

106. Kumar A, Sharma P, Shukla KK, Misra S, Nyati KK. Japanese encephalitis virus:

Associated immune response and recent progress in vaccine development. Mi-crob Pathog. 2019 Nov; 136:103678.

107. Kumar V, Mukharjee S, Akhtar N, Rajan S, Chaturvedi A, Misra S, Gupta S, Pra-

kash P, Das S. Tongue Flap Reconstruction in Carcinoma of Oral Cavity: An Insti-

tutional Experience. J Maxillofac Oral Surg. 2019 Sep;18(3):428–31.

108. Lakshmanan M, Kumar V, Chaturvedi A, Misra S, Gupta S, Akhtar N, Rajan S,

Jain K, Garg S. Role of serum HE4 as a prognostic marker in carcinoma of the

ovary. Indian J Cancer. 2019;56(3):216–21.

109. Modi A, Dwivedi S, Roy D, Khokhar M, Purohit P, Vishnoi J, Pareek P, Sharma S,

Sharma P, Misra S. Growth differentiation factor 15 and its role in carcinogenesis:

an update. Growth Factors. 2019 Aug;37(3–4):190–207.

110. Pahwa HS, Pal AK, Kumar A, Misra S, Kaur G. Cannula-Assisted Port Placement

during Video Endoscopic Inguinal Lymphadenectomy (VEIL)-a Novel and Safe

Technique. Indian J Surg Oncol. 2019 Sep;10(3):570–3.

111. Vishnoi JR, Jain A, Misra S, Pareek P, Rao M, Sureka B, Puranik A. Paraneoplastic

Syndrome Associated with the Retroperitoneal Dedifferentiated Liposarcoma: an

Atypical Presentation and Review of the Literature. Indian J Surg Oncol. 2019

Aug 13;

112. Vishnoi JR, Kumar V, Srivastava K, Misra S. Primary Ewing’s sarcoma of the tem-

poral bone: a rare entity and review of the literature. BMJ Case Rep. 2019

Oct;12(10).

26

113. Vishnoi JR, Misra S. Loco regional flaps a boon for Surgeons in Head and Neck

Reconstruction even in the Era of Microvascular flaps. Vol. 10, Indian J Surg On-col. 2019. p. 575–6.

114. Khichar S, Gopalakrishnan M, Bohra GK, Garg MK, Misra S. “Greet with NA-

MASTE, bye-bye handshake”: a behavioural change campaign for infection pre-

vention in the Emergency Department from Jodhpur, India. Emergency Medicine Journal: EMJ. England; 2020.

115. Kumar V, Rajan S, Gupta S, Akhtar N, Sharma S, Sinha P, Misra S, Chaturvedi A.

Diagnostic Value of Risk of Malignancy Algorithm (ROMA) in Adnexal Masses. J Obstet Gynaecol India. 2020 Jun;70(3):214–9.

116. Mitra P, Misra S, Sharma P. COVID-19 Pandemic in India: What Lies Ahead. In-dian J Clin Biochem: IJCB. 2020. p. 1–3.

117. Saurabh S, Kumar R, Gupta MK, Bhardwaj P, Nag VL, Garg MK, Misra S. Pro-

longed persistence of SARS-CoV-2 in the upper respiratory tract of asymptomatic

infected individuals. QJM. 2020 Jul;

118. Shukla KK, Misra S, Sankanagoudar S, Sharma H, Choudhary GR, Pareek P,

Vishnoi JR, Sharma P. Recent scenario of long non-coding RNAs as a diagnostic

and prognostic biomarker of prostate cancer. Urol Oncol. 2020 Jul;

119. Singh K, Srivastav S, Bhardwaj A, Dixit A, Misra S. Medical Education During the

COVID-19 Pandemic: A Single Institution Experience. Indian Pediatr. 2020 May;

120. Vishnoi JR, Sasidhar A, Misra S, Pareek P, Khera S, Kumar S, Jain A. Hepato-

blastoma in a Young Adult: A Rare Case Report and Review of the Literature. J Gastrointest Cancer. 2020 Mar;51(1):319–24.

121. Mitra P, Suri S, Goyal T, Misra R, Singh K, Garg MK, Misra S, Sharma P. Associ-

ation of Comorbidities with Coronavirus Disease 2019: A Review. Ann Natl Acad Med Sci India. 2020 Jul 4;s-0040-1714159.

27

122. Lingeswaran M, Goyal T, Ghosh R, Suri S, Mitra P, Misra S, et al. Inflammation,

Immunity and Immunogenetics in COVID-19: A Narrative Review. Indian J Clin Biochem. 2020 Jul;35(3):260–73.

123. Maurya CK, Misra R, Sharma P, Singh N, Awasthi H, Agrawal R, Misra S, Sharma

P, et al. Novel Stem Cells and Nucleic Acid-Based Vaccine Trials Against Viral

Outbreak: A Systematic Evaluation During COVID-2019 Pandemic. Indian J Clin Biochem [Internet]. 2020 Jul 10 [cited 2020 Jul 11]; Available from:

http://link.springer.com/10.1007/s12291-020-00907-4.

124. Mittal A, Singh AP, Sureka B, Singh K, Pareek P, Misra S. Telemedicine during

COVID-19 crisis in resource poor districts near Indo-Pak border of western Raja-

sthan. J Family Med Prim Care 2020 (Accepted). 10.4103/jfmpc.jfmpc_1041_20

125. Kanchan T, Saraf A, Krishan K, Misra S. The advantages of virtopsy during the

Covid-19 pandemic. Medico_Legal J 2020 (Accepted).

126. Shekhawat RS, Meshram VP, Kanchan T, Misra S. Privecy and patient confiden-

tiality in times of Covid-19. Medico-Legal J 2020 (Accepted).

127. Kanchal T, Saraf A, Misra S. COVID-19 outbreak: A testing time for medicolegal

facilities in India. J Indian Acad Forensic Med 2020;42(1):1-2.

128. Sureka B, Sinha A, Tak V, Garg M, Bhatia P, Bhardwaj P, Nag VL, Dutt N, Elhence

A, Bhaskar S, BishnoiA, Chauhan N, Bishnoi NR, Misra S. Customized personal

protective equipment (PPE): Solution to conservation and management of supplies

during the coronavirus disease 2019 (COVID-19) pandemic. J Fam Med Prim Care. 2020;9(5):2180 - 2182.

129. Sureka B, Misra S. N95 respirator or Triple layer surgical mask: Radiologist

perspective. Indian J Radiol Imaging 2020 (Accepted).

130. Sureka B, Garg MK, Misra S. N95 respirator and surgical mask in the pandemic

of COVID-19. Ann Thorac Med 2020 (Accepted).

131. Gupta S, Garg S, Kumar v, Chaturvedi A, Misra S, Akhtar N, Rajan S, Kaur J

Lakshmanan L, Jain K. Study of Tumor Transglutaminase 2 expression in

28

Gallbladder cancer –Is it a novel predictor of survival? Annals of Hepato-biliary-

Pancreatic Surgery. (Accepted)

132. Srivastava ,S Jain V, Nag VL, Misra S, Singh K. Current avenues for COVID 19

Serology. Ann Natl Acad Med Sci (India) 2020;00:1–3

Paper on Carcinoma Gallbladder in Lancet Oncology has been judged as one of the top 100 publications from India,

Kaushik R, Indian Surgical literature – top 100 papers. Indian Journal of Sur-gery, 2006. 68.;6 -11.

Investigator in International Research Projects

1. Local Coordinator- in "ATLAS" TRIAL (Adjuvant Tamoxifen Long against Shorter) in collaboration with Oxford University, U.K.

2. Investigator in Trial “A MULTICENTER, RANDOMIZED DOUBLE-BLIND STUDY

OF IDOXIFINE 40 MG/DAY VS TAMOXIFINE 20 MG/DAY AS FIRST LINE HOR-

MONAL THERAPY OF METASTATIC BREAST CANCER IN POSTMENOPAU-

SAL FEMALES”.

3. ‘Clinical study to assess safety, tolerance, efficacy and response to combination

of CAELYX and Paclitaxel for Metastatic Breast Cancer that have failed previous

therapy’.

4. A Phase II study of Gemcitabine plus Cisplatin in Advanced Carcinoma Gallblad-

der.

5. ‘Environmental organochlorine pesticides pollutants and risk of malignant / benign

breast disease’.

6. Principal Investigator - Clinical Trial Protocol No: P276-00/21/08 – An open

label, multicenter phase II study to evaluate efficacy and safety of P276-00 in

Indian subjects with recurrent, metastatic or unresectable locally advanced squa-

mous cell carcinoma of head and neck.

29

7. Principal Investigator - Clinical study A Phase III, Open-label, Randomized,

Multi-center Study of the Effects of Investigational Product, Plus Standard of Care

(Surgery + Radiotherapy or Surgery + Concurrent Chemoradiotherapy) in Sub-

jects with Advanced Primary Squamous Cell Carcinoma of the Oral Cavity / Soft

Palate Versus Standard of Care Only (Protocol Number CS001P3).

8. Principal Investigator - Clinical Trial Protocol Number: MO25515 - An open-

label, multicenter expanded access study of RO5185426 in patients with meta-

static melanoma.

9. Principal Investigator- CANscript™ Clinical Outcomes in a Real-World Setting

(ANCERS-1): A Prospective, Multicenter, Observational Study Examining the

Clinical Utility of CANscript™ in Routine Clinical Practice.

10. Principal Investigator- Determinants of Mortality due to COVID in India: Case

Control Multi Centric Study.

11. Principal Investigator- Outcomes of surgery in COVID-19 infection: international

cohort study (CovidSurg).

12. Principal Investigator- Outcomes of elective cancer surgery during the COVID-

19 pandemic crisis: an international, multicentre, observational cohort study

(CovidSurg-Cancer).

13. Principal Investigator- Clinical Trial Protocol Number: CTRI/2020/02/023606-

Cluster randomised trial of sterile glove and instrument change at the time of

wound closure to reduce surgical site infection (ChEETAh Trial).

14. Principal Investigator- Clinical Trial Protocol Number: CTRI/2020/06/026196-

Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19

(PROTECT-Surg Trial).

15. Principal Investigator- Perioperative respiratory care and outcomes for patients

undergoing high risk abdominal surgery (PENgUIN Trial).

16. Co-Principal Investigator- Evaluating the dynamics of breast cancer stem cells

and miRNA 155 in patients undergoing systemic neoadjuvant or palliative chem-

otherapy for breast cancer

30

17. Co-Principal Investigator- Immunohistochemical validation of TLE-1, Nuclear

beta-catenin and MIB-1 in soft tissue sarcomas with RT-PCR based correlation

of SYT-SSX in cases of Synovial sarcomas.

18. Co-Principal Investigator- Correlation of miR 155 and miR101 expression with c-

fos in patients of Oral submucous fibrosis and Oral squamous cell carcinoma

19. Co-Principal Investigator- Association of miR-21, miR-141, miR-145 and miR10b

in the induction and propagation of cancer stem cell in prostate cancer.

20. Co-Principal Investigator- To understand the diagnostic and prognostic signifi-

cance of circulating miRNAs expression in prostate cancer patients.

21. Co-Principal Investigator- Correlation of apoptosis, angiogenesis and cell regu-

lating miRNA (miR 221-3p, miR133a-3p and miR 9-5p) with global methylation

and promoter-specific methylation of the P16, SOCS-1, and SHP-1 genes and

their expression in patients of oral submucous fibrosis and oral squamous cell

carcinoma.

22. Co-Principal Investigator- Evaluating the concentrations of heavy metals in the

oral sub mucous fibrosis and oral cancer patients using blood and saliva as diag-

nostic mediums.

23. Co-Principal Investigator- Evaluating the dynamics of breast cancer stem cells

with apoptosis, necrosis, angiogenesis and cell cycle regulating miRNA (miR 221-

3p, miR133a-3p and miR 9-5p) in patients undergoing systemic neoadjuvant or

palliative chemotherapy for breast cancer.

24. Co-Principal Investigator- A cross-sectional study analysing role of GDF-15 in in-

duction of stemness of Triple negative breast cancer (TNBC).

25. Co-Principal Investigator- A study of the correlation between the miR-221-3p,

miR-133a-3p and miR-9-5p expression levels and clinicopathological character-

istics of oral squamous cell carcinoma.

26. Co-Principal Investigator- The impact of preservation versus division of inter-

costobrachial nerve during axillary dissection in breast cancer patients on chronic

post-surgical pain, sensory changes and quality of life: A prospective comparative

study.

31

27. Co-Principal Investigator- Medical Education during the COVID-19 Pandemic:

AIIMS Jodhpur Experience.

28. Co-Principal Investigator- Status of Sero-positivity among asymptomatic front-line

workers during the lockdown period due to COVID-19 pandemic in Jodhpur.

29. Co-Principal Investigator- Predicting COVID-19 Morbidity and Mortality through

Epidemiological modelling: A Data Mining Approach.

30. Co-Principal Investigator- Risk factors for developing symptomatic COVID-19 as

compared to asymptomatic SARS-CoV2 infection in Jodhpur, India

31. Co-Principal Investigator- Opportunities, Strategies, & Challenges while using

Telemedicine for Palliative Care of Cancer Patients during COVID-19: A Pilot

study

32. Co-Principal Investigator- A Study to assess knowledge, attitude and practices of

health workers towards environmental cleaning in regards to COVID-19

33. Co-Principal Investigator- Study of perception and attitude of family members of

health workers engaged in management of COVID-19

34. Co-Principal Investigator- Airport Screening in COVID-19 Disease Pandemic at

Capital City of Rajasthan: Outcome and Challenges

35. Co-Principal Investigator- A study to assess Knowledge, attitude and practices of

healthcare workers on use of personal protective equipment's in regards to

COVID-19

36. Co-Principal Investigator- Home Vs Facility based isolation and quarantine in

Jodhpur during COVID-19 pandemic: An exploratory study

37. Co-Principal Investigator- Enhanced testing, tracing and tracking strategy

(ETTTS) for effective containment of COVID-19 in Jodhpur

38. Co-Principal Investigator- Outcomes of infants born to COVID-19 positive moth-

ers: A Prospective cohort study

32

39. Co-Principal Investigator- Case series of suspected patients of COVID-19 with

SARI admitted in medical intensive care unit at a tertiary care centre after lock

down in India

40. Co-Principal Investigator- Assessment of Quality Improvement Initiatives for in-

fection control in AIIMS Jodhpur

41. Co-Principal Investigator- Improving Quality of Medical Education through evalu-

ation of multiple thematic opportunities in instructional methods and Assessment

created during COVID-19 Pandemic

42. Co-Principal Investigator- Online Microteaching Comparison of two methods for

Faculty Teaching Skills during COVID-19 and Post COVID-19

43. Co-Principal Investigator- Viral RNA Shedding and Transmission Potential of

Asymptomatic and Paucisymptomatic COVID-19 Infections

44. Co-Principal Investigator- Evaluation of Efficacy and Safety of Ayurveda Interven-

tion (Ayush-64) add-on therapy for patients with COVID-19 infection (Stage I) -

An open labelled, Parallel Group, Randomized controlled clinical trial

45. Co-Principal Investigator- Effect of a face masks on cognitive and cardiorespira-

tory parameters at rest and exercise

46. Co-Principal Investigator- QuantiFERON-TB GOLD (IGRA) levels and Clinical

Outcomes in COVID-19 patients